Patents by Inventor William Raab

William Raab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9388449
    Abstract: Methods and materials are disclosed for use in an enzyme fragment complementation assay using complementary fragments of ?-galactosidase to study the trafficking of proteins in a cell. Compounds that bind to a target peptide have been found to affect protein folding and therefore trafficking. ?-Galactosidase fragments, an enzyme donor (ED) and an enzyme acceptor (EA), are fused to a target peptide and to an intracellular compartment protein, wherein the compartment is involved in intracellular trafficking. Contacting the cell with a compound that binds to the target peptide results in enhanced movement of the protein through the cellular trafficking pathway comprised of the endoplasmic reticulum, Golgi apparatus, the plasma membrane, endosomes, etc. Using this approach, compounds that bind to a target peptide and alter its ability to traffic through the normal cellular pathway can be readily detected.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: July 12, 2016
    Assignee: DISCOVERX CORPORATION
    Inventors: Thomas S. Wehrman, Daniel Bassoni, William Raab
  • Patent number: 9185083
    Abstract: A method and apparatus for concealing data to be transmitted within an environment. A sound frequency map is identified based on sounds detected within the environment. A number of audio symbols for use in representing a number of data blocks in the data to be transmitted within the environment are selected using the sound frequency map. An encrypted audio signal is formed using the number of audio symbols.
    Type: Grant
    Filed: May 23, 2013
    Date of Patent: November 10, 2015
    Assignee: THE BOEING COMPANY
    Inventors: John William Glatfelter, Christopher William Raab
  • Patent number: 8945853
    Abstract: Methods and compositions are provided to measure the binding of a test compound to a target peptide by measuring the effect of the compound on the abundance of the target peptide inside a cell. The target peptide may bind the test compound at an active site or an allosteric site, and it has been found that such binding may stabilize the target peptide against cellular degradation. The target peptide will preferably comprise a destabilizing mutation which shortens the half life of the target peptide within the cell, typically a mammalian cell. Test compounds, including small molecules, have been found to stabilize target peptides. Also provided are systems and kits for use in practicing the methods.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: February 3, 2015
    Assignee: DiscoveRx Corporation
    Inventors: William Raab, Thomas S. Wehrman
  • Publication number: 20140045194
    Abstract: Methods and materials are disclosed for use in an enzyme fragment complementation assay using complementary fragments of ?-galactosidase to study the trafficking of proteins in a cell. Compounds that bind to a target peptide have been found to affect protein folding and therefore trafficking. ?-Galactosidase fragments, an enzyme donor (ED) and an enzyme acceptor (EA), are fused to a target peptide and to an intracellular compartment protein, wherein the compartment is involved in intracellular trafficking. Contacting the cell with a compound that binds to the target peptide results in enhanced movement of the protein through the cellular trafficking pathway comprised of the endoplasmic reticulum, Golgi apparatus, the plasma membrane, endosomes, etc. Using this approach, compounds that bind to a target peptide and alter its ability to traffic through the normal cellular pathway can be readily detected.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: DiscoveRx Corporation
    Inventors: Thomas S. Wehrman, Daniel Bassoni, William Raab
  • Patent number: 8569057
    Abstract: Methods and materials are disclosed for use in an enzyme fragment complementation assay using complementary fragments of ?-galactosidase to study the trafficking of proteins in a cell. Compounds that bind to a target peptide have been found to affect protein folding and therefore trafficking. ?-Galactosidase fragments, an enzyme donor (ED) and an enzyme acceptor (EA), are fused to a target peptide and to an intracellular compartment protein, wherein the compartment is involved in intracellular trafficking. Contacting the cell with a compound that binds to the target peptide results in enhanced movement of the protein through the cellular trafficking pathway comprised of the endoplasmic reticulum, Golgi apparatus, the plasma membrane, endosomes, etc. Using this approach, compounds that bind to a target peptide and alter its ability to traffic through the normal cellular pathway can be readily detected.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: October 29, 2013
    Assignee: DiscoveRx Corporation
    Inventors: Thomas S. Wehrman, Daniel Bassoni, William Raab
  • Publication number: 20120329075
    Abstract: Methods and materials are disclosed for use in an enzyme fragment complementation assay using complementary fragments of ?-galactosidase to study the trafficking of proteins in a cell. Compounds that bind to a target peptide have been found to affect protein folding and therefore trafficking. ?-Galactosidase fragments, an enzyme donor (ED) and an enzyme acceptor (EA), are fused to a target peptide and to an intracellular compartment protein, wherein the compartment is involved in intracellular trafficking. Contacting the cell with a compound that binds to the target peptide results in enhanced movement of the protein through the cellular trafficking pathway comprised of the endoplasmic reticulum, Golgi apparatus, the plasma membrane, endosomes, etc. Using this approach, compounds that bind to a target peptide and alter its ability to traffic through the normal cellular pathway can be readily detected.
    Type: Application
    Filed: June 22, 2012
    Publication date: December 27, 2012
    Applicant: DISCOVERX CORPORATION
    Inventors: Thomas S. Wehrman, Daniel Bassoni, William Raab
  • Patent number: 8211655
    Abstract: A method for determining ligand activation of receptors using cells expressing genetic constructs of a fusion protein of at least a binding domain of an auxiliary protein and a fragment of ?-galactosidase, a fusion protein of an endosome-associated protein and a complementary fragment of ?-galactosidase, and a wild-type receptor. The receptors are characterized by binding to the auxiliary protein-binding domain upon activation by an agonist and then endocytosing associated with an endosome to which the endosome-associated protein binds. Cells are incubated with a candidate ligand followed by lysis with a lysing medium comprising a substrate for the ?-galactosidase. The enzyme product is then detected as a measure of the activation of the receptor.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: July 3, 2012
    Assignee: Discoverx Corporation
    Inventors: Thomas S. Wehrman, William Raab, Chin Yee Loh
  • Publication number: 20120040372
    Abstract: Methods for detecting phosphorylation of receptor tyrosine kinases (“RTKs”) upon activation and the modulation of activation by a candidate compound are provided. The method employs cells comprising two fusion products: (1) an RTK fused to a small fragment of ?-galactosidase and (2) a phosphotyrosine binding peptide fused to the large fragment of ?-galactosidase, where the 2 fragments weakly complex to form an active enzyme, and optionally a construct for a cytosolic RTK phosphorylating kinase, when the RTK does not autophosphoryate. To detect phosphorylation a ?-galactosidase substrate is added to the cells, whereby product formation indicates the occurrence of phosphorylation.
    Type: Application
    Filed: October 25, 2011
    Publication date: February 16, 2012
    Applicant: DISCOVERX CORPORATION
    Inventors: Wei Feng, William Raab, Philip Achacoso, Thomas Wehrman, Keith R. Olson
  • Patent number: 8067155
    Abstract: Methods for detecting phosphorylation of receptor tyrosine kinases (“RTKs”) upon activation are provided. The method employs cells comprising two fusion products: (1) an RTK fused to a small fragment of ?-galactosidase and (2) a phosphotyrosine binding peptide fused to the large fragment of ?-galactosidase, where the 2 fragments weakly complex to form an active enzyme, and optionally a construct for a cytosolic RTK phosphorylating kinase, when the RTK does not autophosphoryate. To detect phosphorylation a ?-galactosidase substrate is added to the cells, whereby product formation indicates the occurrence of phosphorylation.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: November 29, 2011
    Assignee: DiscoveRx Corporation
    Inventors: Wei Feng, William Raab, Philip Achacoso, Thomas Wehrman, Keith R. Olson
  • Publication number: 20100203555
    Abstract: A method for determining ligand activation of receptors using cells expressing genetic constructs of a fusion protein of at least a binding domain of an auxiliary protein and a fragment of ?-galactosidase, a fusion protein of an endosome-associated protein and a complementary fragment of ?-galactosidase, and a wild-type receptor. The receptors are characterized by binding to the auxiliary protein-binding domain upon activation by an agonist and then endocytosing associated with an endosome to which the endosome-associated protein binds. Cells are incubated with a candidate ligand followed by lysis with a lysing medium comprising a substrate for the ?-galactosidase. The enzyme product is then detected as a measure of the activation of the receptor.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 12, 2010
    Applicant: DISCOVERX CORPORATION
    Inventors: Thomas S. Wehrman, William Raab, Chin Yee Loh
  • Publication number: 20100041052
    Abstract: Methods for detecting phosphorylation of receptor tyrosine kinases (“RTKs”) upon activation are provided. The method employs cells comprising two fusion products: (1) an RTK fused to a small fragment of ?-galactosidase and (2) a phosphotyrosine binding peptide fused to the large fragment of ?-galactosidase, where the 2 fragments weakly complex to form an active enzyme, and optionally a construct for a cytosolic RTK phosphorylating kinase, when the RTK does not autophosphoryate. To detect phosphorylation a ?-galactosidase substrate is added to the cells, whereby product formation indicates the occurrence of phosphorylation.
    Type: Application
    Filed: August 6, 2009
    Publication date: February 18, 2010
    Applicant: DISCOVERX CORPORATION
    Inventors: Wei Feng, William Raab, Philip Achacoso, Thomas Wehrman, Keith R. Olson